The International Consortium for Health Outcomes Measurement (ICHOM), an independent non-profit organisation with offices in Cambridge, Massachusetts and London, England, has named physician-entrepreneur Dr Neil Bacon as its new president and CEO, effective immediately, it is reported today.
Dr Bacon succeeds Dr Christina Akerman, who has returned to her native Sweden after four years as president. Dr Bacon, a nephrologist trained at Oxford and Harvard, is a distinguished academic clinician and health information technology entrepreneur. He is internationally recognised leader in quality measurement and engaging patients in their health. Dr Bacon founded Doctors.net.uk in 1996. In recognition of his contributions utilising the Internet to improve healthcare, he was named a Fellow of the Royal College of Physicians in London in 2015. In 2008, Dr Bacon founded iWantGreatCare, an independent organisation enabling patients to rate and review their doctors, dentists, hospitals, after-care facilities, and medications where he was CEO. With reviews from more than five million patients in 23 countries, iWantGreatCare has become a powerful tool for driving health care improvement worldwide.
Harvard Business School professor Michael Porter, ICHOM co-founder and chairman of the board, said, 'Dr Neil Bacon is a pioneer and entrepreneur in use of information technology to enhance quality measurement and change health care. Universal measurement of outcomes that matter to patients, medical condition by medical condition, is the most powerful single tool to change health care.'
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business